Synopsis
Turn an incidental pulmonary nodule into a proportionate, documented pathway using prior imaging, CT phenotype and validated malignancy risk while addressing other actionable thoracic findings.
- A pulmonary nodule is an imaging description, not a diagnosis; first confirm that the apparent opacity is intrapulmonary and characterise it on thin-section CT.
- Retrieve all prior chest imaging before ordering serial scans because long-term stability, true growth or a previously overlooked lesion can change the pathway immediately.
- Risk assessment integrates age, smoking, cancer history, nodule size, morphology and location; use the BTS-endorsed Brock model in its intended population rather than intuition alone.
- Volumetry is preferred when available because small diameter changes are difficult to measure reproducibly; compare technique and calculate volume-doubling behaviour through the formal pathway.
- Solid, part-solid and pure ground-glass nodules have different natural histories and surveillance logic; do not apply one schedule to all three.
- PET-CT refines risk only when the lesion is large enough for reliable characterisation; inflammation can be avid and indolent or small malignancies can be falsely negative.
- The decision after risk stratification is shared among discharge, CT surveillance, biopsy, resection or non-surgical treatment, accounting for fitness and whether tissue would change care.
- An incidental scan may also reveal emphysema, interstitial abnormality, pleural disease, infection, airway obstruction or coronary calcification; each needs explicit triage rather than a generic repeat scan.
Key red flags
Haemoptysis, a central obstructing lesion, lobar collapse, suspicious lymphadenopathy or a rapidly enlarging mass should enter an urgent lung-cancer pathway rather than routine nodule surveillance.
A new nodule with sepsis, immunosuppression, cavitation or possible embolic infection needs prompt clinical assessment; delaying behind a standard interval scan may be unsafe.
New focal neurological deficit, spinal pain, pathological fracture or severe hypercalcaemic symptoms alongside a suspicious nodule may indicate metastatic disease and requires urgent parallel care.
Never allow an incidental result to remain unowned: failure to communicate the plan, surveillance date and responsible team is a patient-safety event.
Investigation priorities
Establish whether the lesion is new, stable or genuinely growing.
Management branches
A chest radiograph or CT report describes a new solitary or multiple pulmonary nodule.
- Retrieve prior imaging and clinical context, including smoking, earlier malignancy, immune status, symptoms and whether an acute infective process is plausible.
- Obtain or reconstruct appropriate thin-section CT, documenting number, attenuation, morphology, lobe, dimensions or volume and every relevant non-nodule finding.
- Identify benign diagnostic patterns and context exceptions before applying routine surveillance; escalate masses, obstruction or urgent cancer features directly.
- Give the patient a clear written result, explanation of uncertainty, named responsible service and the next action with an expected timeframe.